Baxter director receives 12,836-share stock grant
SCHLICHTING NANCY M reported acquisition or exercise transactions in this Form 4 filing.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
SCHLICHTING NANCY M reported acquisition or exercise transactions in this Form 4 filing.
Baxter International Inc. director Nancy M. Schlichting reported an equity compensation grant of common stock. On May 5, 2026, she received 12,836 fully vested shares of Baxter common stock at a stated price of $0.00 per share, reflecting a grant or award rather than an open-market purchase. Following this grant, her direct holdings increased to 34,994 shares of common stock. The total reported share balance includes the automatic reinvestment of dividends.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock, $1 par value | 12,836 | $0.00 | $0.00 |
Footnotes (2)
- F1. The reporting person received a grant of fully vested shares of common stock of Baxter International Inc., subject to the terms and conditions of the applicable grant.
- F2. Total includes the automatic reinvestment of dividends.
Key Figures
Key Terms
automatic reinvestment of dividends financial
grant, award, or other acquisition financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Baxter (BAX) report for Nancy Schlichting?
Was Nancy Schlichting’s Baxter (BAX) stock grant an open-market purchase?
What type of security did Nancy Schlichting receive in this Baxter (BAX) Form 4?
AI-generated analysis. How Rhea-AI works. Not financial advice.